Lexicon Pharmaceuticals, Inc. SEC filings LXRX

Lexicon Pharmaceuticals, Inc. has 1,003 filings in SEC EDGAR's recent list, going back to Jan 8, 2010. Its latest annual report, Form ARS, was filed on Mar 16, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.

Form Description Filed Period
ARS Annual report to shareholders Mar 16, 2026 Dec 31, 2025
10-K Annual report Mar 5, 2026 Dec 31, 2025
ARS Annual report to shareholders Apr 22, 2025 Dec 31, 2024
10-K Annual report Mar 7, 2025 Dec 31, 2024
ARS Annual report to shareholders Mar 26, 2024 Dec 31, 2023
10-K Annual report Mar 25, 2024 Dec 31, 2023
10-K Annual report Mar 3, 2023 Dec 31, 2022
10-K Annual report Mar 10, 2022 Dec 31, 2021
10-K Annual report Mar 12, 2021 Dec 31, 2020
10-K Annual report Mar 12, 2020 Dec 31, 2019
10-K Annual report Mar 15, 2019 Dec 31, 2018
10-K Annual report Mar 1, 2018 Dec 31, 2017
10-K Annual report Mar 6, 2017 Dec 31, 2016
10-K/A Amended annual report Jun 14, 2016 Dec 31, 2015
10-K Annual report Mar 11, 2016 Dec 31, 2015
ARS Annual report to shareholders Mar 16, 2015 Dec 31, 2014
10-K Annual report Mar 12, 2015 Dec 31, 2014
ARS Annual report to shareholders Mar 18, 2014 Dec 31, 2013
10-K Annual report Mar 7, 2014 Dec 31, 2013
ARS Annual report to shareholders Mar 29, 2013 Dec 31, 2012
10-K Annual report Mar 11, 2013 Dec 31, 2012
ARS Annual report to shareholders Mar 19, 2012 Dec 31, 2011
10-K Annual report Mar 8, 2012 Dec 31, 2011
ARS Annual report to shareholders Mar 21, 2011 Dec 31, 2010
10-K Annual report Mar 16, 2011 Dec 31, 2010
ARS Annual report to shareholders Mar 22, 2010 Dec 31, 2009
10-K Annual report Mar 8, 2010 Dec 31, 2009

Showing 27 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
LXRX (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
The Woodlands, TX
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1062822
Former names
LEXICON PHARMACEUTICALS, INC./DE (until Dec 5, 2014); LEXICON GENETICS INC/TX (until Apr 2, 2007)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.